escitalopram placebo

DRUG3 trials

Sponsors

H. Lundbeck A/S, Laboratório Catarinense SA, Shanghai 7th People's Hospital

Conditions

DepressionDepressive Disorder, MajorMajor Depressive Disorder

Phase 2

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

CompletedNCT00807248

H. Lundbeck A/SMajor Depressive Disorder

Start: 2008-11-30End: 2010-02-28Updated: 2012-12-17

Phase 3

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

TerminatedNCT02532660

Laboratório Catarinense SADepression

Start: 2018-07-02End: 2022-06-01Updated: 2022-06-16

Unknown Phase

Acupuncture and Escitalopram for Treating Major Depression Clinical Study

Not yet recruitingNCT05901571

Shanghai 7th People's HospitalDepressive Disorder, Major

Start: 2026-11-01End: 2030-02-01Target: 216Updated: 2026-03-11

Related Papers

Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS): protocol for a factorial randomised controlled trial

BMJ Open2024-09-011 citations